Home
Promomed

Promomed Market Share Analysis for July 2026

«промомед» – ведущая инновационная биофармацевтическая компания с потенциалом значительного роста в перспективных сегментах фармацевтического рынка.

Health > Biotechnology and Pharmaceuticals

Domainpromomed.ru

Year Founded2005

Employees1001 - 5000

Annual Revenue--

Promomed

Promomed (including company regionals)

promomed.ru

See more website traffic and engagement information

Total visits to Promomed's top domains

Understand Promomed market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

promomed.ru5K

See more with Sales Intelligence

Avg. visit duration in Promomed's top domains

Analyze Promomed engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

promomed.ru00:00:37

See more with Sales Intelligence

Avg. pageviews on Promomed's top domains

See how Promomed keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

promomed.ru1.82

See more with Sales Intelligence

Promomed top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Promomed

These are the website technologies, by industry, used by Promomed top domains

Advertising (3)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Social (3)

Instagram

Content Management System (2)

Bitrix

More Technologies

6

See all

News & Signals from Promomed

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPromomed Group expands offices in Uzbekistan, Central Asia, Asia.Promomed is strengthening its presence in Uzbekistan.

NewsPromomed Group is developing generic versions of Novo Nordisk's semaglutide on Jun 23rd '26.The Russian government has extended pharmaceutical company Promomed's right to produce generic versions of Novo Nordisk's semaglutide, which is the active ingredient in the diabetes drug Ozempic and the weight-loss drug Wegovy.

NewsPromomed Group is developing Vilpramycin SAR.The Russian biopharmaceutical company Promomed has announced the start of a medical study for its new antibiotic Vilpramycin SAR(R)(active ingredient: josamycin).